Mechanical and bioprosthetic valves in young women: a systematic review and meta-analysis of cardiac, maternal, and fetal outcomes

Main Article Content

I Komang Adhi Parama Harta
Putu Febry Krisna Pertiwi
Ketut Putu Yasa
I Wayan Sudarma

Keywords

bioprosthetic valve, heart valve replacement, mechanical prosthetic valve, pregnancy, young women

Abstract

Valve replacement for the heart in young women, particularly those who are pregnant, is challenging. It requires finding the right balance between valve durability, managing anticoagulation, and ensuring positive reproductive outcomes. This systematic review and meta-analysis compared mechanical prosthetic (MP) and bioprosthetic valves (BP) across cardiac, maternal, and fetal outcomes. Nine studies were included following a comprehensive literature search. The analysis revealed MACE involving MP and BP were not significantly different (OR: 1.31, 95% CI: 0.82–2.09, p = 0.26). Thromboembolic events were significantly more frequent in the MP group (OR: 6.59, 95% CI: 3.41–12.74, p < 0.001), while structural valve deterioration (SVD) occurred more often in BP recipients (OR: 0.01, 95% CI: 0.00–0.70, p = 0.03). Maternal outcomes showed a higher risk of pregnancy loss in MP recipients (OR: 4.62, 95% CI: 1.87–11.40, p < 0.001). Preterm delivery was more common went down in the MP group, but it wasn't enough to warrant statistical analysis (OR: 2.20, 95% CI: 0.86–5.58, p = 0.10). For reoperation or redo surgery, MP had lower risk and showed superior results than BP (OR: 0.06, 95% CI: 0.01–0.32, p = 0.001). These findings highlight the complexities involved in choosing between valve types. Although MP valves last longer, they increase the likelihood of thromboembolic events and miscarriage. While improving results for both the mother and the unborn child, BP valves, are prone to structural deterioration, necessitating reoperation. Individualized treatment decisions that consider patient preferences, clinical context, and reproductive plans are essential to optimizing outcomes for young women requiring valve replacement.

Abstract 41 | pdf Downloads 48

References

1. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Archives of internal medicine. 2000;160(2):191–6.
2. Marro M, Kossar AP, Xue Y, Frasca A, Levy RJ, Ferrari G. Noncalcific Mechanisms of Bioprosthetic Structural Valve Degeneration. Journal of the American Heart Association. 2021;10(3):e018921.
3. Ng AP, Verma A, Sanaiha Y, Williamson CG, Afshar Y, Benharash P. Maternal and Fetal Outcomes in Pregnant Patients With Mechanical and Bioprosthetic Heart Valves. Journal of the American Heart Association. 2023;12(10):e028653.
4. Lawley CM, Algert CS, Ford JB, Nippita TA, Figtree GA, Roberts CL. Heart valve prostheses in pregnancy: outcomes for women and their infants. Journal of the American Heart Association. 2014;3(3):e000953.
5. Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372.
6. Bosco E, Hsueh L, McConeghy KW, Gravenstein S, Saade E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC medical research methodology. 2021;21(1):241.
7. Roudaut R, Serri K, Lafitte S. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart (British Cardiac Society). 2007;93(1):137–42.
8. Wells G, Shea B, O’Connell D, Peterson je, Welch V, Losos M, et al. The Newcastle–Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis. ᅟ. 2000;ᅟ.
9. North RA, Sadler L, Stewart AW, McCowan LME, Kerr AR, White HD. Long-term survival and valve-related complications in young women with cardiac valve replacements. Circulation. 1999;99(20):2669–76.
10. Sadler L, McCowan L, White H, Stewart A, Bracken M, North R. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG: An International Journal of Obstetrics and Gynaecology. 2000;107(2):245–53.
11. Bozso SJ, White A, Kang JJH, Hong Y, Norris CM, Lakey O, et al. Long-term Outcomes Following Mechanical or Bioprosthetic Aortic Valve Replacement in Young Women. CJC Open. 2020;2(6):514–21.
12. Batra J, Itagaki S, Egorova NN, Chikwe J. Outcomes and Long-term Effects of Pregnancy in Women With Biologic and Mechanical Valve Prostheses. American Journal of Cardiology. 2018;122(10):1738–44.
13. Lameijer H, van Slooten YJ, Jongbloed MRM, Oudijk MA, Kampman MAM, van Dijk AP, et al. Biological versus mechanical heart valve prosthesis during pregnancy in women with congenital heart disease. International Journal of Cardiology. 2018;268(2017):106–12.
14. Lawley CM, Algert CS, Ford JB, Nippita TA, Figtree GA, Roberts CL. Heart valve prostheses in pregnancy: Outcomes for women and their infants. Journal of the American Heart Association. 2014;3(3):1–8.
15. Singab H, Sami G. Mitral valve bioprosthesis is safer han mechanical mitral prosthesis in young women. Heart Surgery Forum. 2020;23(5):E677–84.
16. Bouhout I, Poirier N, Mazine A, Dore A, Mercier LA, Leduc L, et al. Cardiac, obstetric, and fetal outcomes during pregnancy after biological or mechanical aortic valve replacement. Canadian Journal of Cardiology. 2014;30(7):801–7.
17. Economy KE, Valente AM. Mechanical Heart Valves in Pregnancy. Circulation. 2015;132(2):79–81.
18. Suri V, Keepanasseril A, Aggarwal N, Chopra S, Bagga R, Sikka P, et al. Mechanical valve prosthesis and anticoagulation regimens in pregnancy: A tertiary centre experience. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2011;159(2):320–3.
19. Belluschi I, Buzzatti N, Castiglioni A, De Bonis M, Maisano F, Alfieri O. Aortic and mitral bioprosthetic valve dysfunction: Surgical or percutaneous solutions? European Heart Journal, Supplement. 2021;23:E6–12.
20. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. British Heart Journal. 1994;71(2):196 LP – 201.
21. Soma-Pillay P, Nene Z, Mathivha TM, Macdonald AP. The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valves. Obstetric medicine. 2011;4(1):24–7.